Literature DB >> 29226266

The Influence of Race and Ethnicity on Becoming a Human Subject: Factors Associated with Participation in Research.

Mary A Garza1, Sandra Crouse Quinn2, Yan Li3, Luciana Assini-Meytin1, Erica T Casper4, Craig S Fryer1, James Butler1, Natasha A Brown1, Kevin H Kim1, Stephen B Thomas5.   

Abstract

INRODUCTION: The purpose of this study was to explore factors associated with willingness of African Americans and Latinos to participate in biomedical and public health research and to delineate factors that influences the decision to become a human subject.
METHODS: We present results from a 2010 random digit-dial telephone survey of 2,455 African American (N= 1,191) and Latino (N= 1,264) adults. We used standard measures to assess knowledge of research, terminology, informed consent procedures, previous participation in research, health care experiences, social support, risk perception, religiousness, and trust.
RESULTS: Over 60% of both African Americans and Latinos reported they believed people in medical research are pressured into participating. Over 50% said that it was not at all important to have someone of the same race/ethnicity ask them to participate. In a sub-sample of 322 African Americans and 190 Latinos who had previously been asked to participate in a research study, 63% of African Americans and 65% of Latinos consented to participate in a study. Finally, both African Americans (57%) and Latinos (68%) reported willingness to participate in future research. Overall, the multivariate analysis explained 29% of the variability in willingness to participate in future research.
CONCLUSIONS: Results suggest that African Americans and Latinos have no automatic predisposition to decline participation in research studies. These results can inform culturally tailored interventions for ethical recruitment of minorities into research and clinical trials.

Entities:  

Year:  2017        PMID: 29226266      PMCID: PMC5716487          DOI: 10.1016/j.conctc.2017.05.009

Source DB:  PubMed          Journal:  Contemp Clin Trials Commun        ISSN: 2451-8654


Introduction

Including racial and ethnic minorities in research is critical for generalizability of results and for providing equal opportunities to all people who may benefit from participation in research. Despite one article that suggests that minorities are overrepresented in Phase I drug clinical trials [1], evidence still confirms low participation in research [2], [3], [4]. Numerous studies seek to explain the reasons for the low participation in research [5], [6], [7], [8], [9], identifying both barriers and motivators/facilitators to participation [5], [6], [10], [11], [12], [13], and examining minority willingness to participate as a proxy for actual participation [12], [14], [15], [16], [17]. While these studies are varied, general consensus is that racial and ethnic minorities have generally positive attitudes toward research and are as willing as Whites to participate in research across different study types [9], [12], [14], [15], [16], [17]. Not surprisingly, willingness to participate tends to depend upon the risks and level of invasiveness [15], [18], [19]. At the same time, however, researchers are documenting that there are significant differences in the numbers of minorities being asked to participate, far lower than would be expected based on minority representation in the country [9]. Additional studies suggest that minorities are less aware of research and research opportunities than Whites, and may rely more on their physicians or other health care professionals to provide information about research trials [12], [20], [21], [22]. Yet, despite this need for communication about research studies, physician bias, both in treatment of minority patients and in the belief that minorities will not comply, may lead physicians to refrain from asking, thereby perpetuating the lower participation [1], [23]. One approach for increasing minority participation in research has been to include “race matching” as a recruitment strategy. This approach has been adopted from research indicating greater patient satisfaction, longer visit times, and improved care in race matched physician-patient relationships [24], [25]. While a few studies suggest that racially-matched minority researchers may increase willingness to participate, others highlight researcher characteristics other than race, such as honesty, openness and shared values, as more important contributors to recruitment success [20], [26]. These studies are largely qualitative, and little empirical evidence exists to either support or refute the importance of race matching. In an effort to further our understanding of minority willingness to participate in research and to elucidate some of the factors that influence the decision on joining a research trial, we conducted a unique study that included an all-minority sample of African Americans and Latinos who live in predominantly minority neighbourhoods. Via a random telephone survey, African Americans and Latinos responded to queries about their willingness to participate in different types of research, with different levels of invasiveness, motivations and barriers to participation, prior participation, perceived benefits of research, and attitudes toward their physician, researchers and research, in general. Analysis of the data allowed us to identify some key areas where researchers can tailor their recruitment strategies to help improve their inclusion of minorities in their research.

Methods

Study sample

ICF-MACRO, an international research firm, conducted the survey from June to December 2010 with 2455 African Americans (N = 1191) and Latinos (N = 1264).

Eligibility criteria

Prospective participants completed a telephone screener to assess their eligibility, which consisted of the following five questions: 1. Are you 18 years of age or older? 2. Are you of Hispanic or Latino background?; 2A. Which one of these groups best describes your own ethnic identification? (e.g., Mexican/Chicano, Puerto Rican, Cuban); 3. What is your race? (e.g., African American/Black, Asian, Caucasian/White, Native Hawaiian/Pacific Islander); 4. Would you consider your racial background to include Black or African American ancestry? Prospective participants were randomly selected based on telephone exchanges associated with geographic areas of high concentrations of African Americans and Latinos. To identify the exchanges, directory-listed telephone numbers were mapped and assigned to a specific geographic location (census block group, census tract, or zip code); those exchanges with an estimated concentration of African Americans and Latinos of at least 40% were used. Four geographical regions were identified with a substantial sample size (>250) for each region -Northeast, Midwest, South, and West (See Table 1 for the distribution of study respondents by region). The overall response rate was 20.3%, which is consistent with response rates from other current random-digit-dial surveys [27], [28]. Sampling weights were calculated and stratified sampling was conducted to select telephone numbers for five strata defined by the estimated concentration of African Americans and Latinos within exchanges. The resulting sample represents African American and Latino populations who live in predominantly African American/Latino neighbourhoods. The survey took an average of 30 min to complete and it was offered in both English and Spanish. University of Pittsburgh Institutional Review Board approved the study and the free and informed consent of all participants was obtained.
Table 1

Distribution of respondents by region.

Frequency NPercent %Cumulative %.
Northeast31913.713.7
Midwest29412.6226.32
South101143.4169.73
West70530.27100
Distribution of respondents by region.

Measures

Socio-Demographics: Eight socio-demographic variables were measured: race, ethnicity, gender, age, education, marital status, health insurance, and income. We collapsed education into below college and college or above, and marital status into married or living with a partner and other. Income was collapsed into below $36,000, $36,000 to $76,000 and above $76,000. Participants' health status was measured on a 5-point Likert scale (1 = poor to 5 = excellent). Additional survey questions covered the topics of: willingness to participate, previous participation in research, value of human subjects research, motivations for participation, patient-provider interactions, beneficiaries of research, attitudes about research, researcher honesty, experimentation, race matching, and knowledge about the Tuskegee Study [29]. Questions and potential responses are shown in Table 2, including how some of the variables were constructed.
Table 2

Survey questions.

MeasureSurvey Question(s)Possible Responses
Willingness to ParticipateIf you were asked to be a subject in a medical research study, do you think that you would or would not agree to participate?4. Definitely would3. Probably would2. Probably would not1. Definitely would notDichotomized to yes/no (yes = probable would, definitely wouldno = probably would not, definitely would not)
How likely are you to participate in a medical study if the study required you to (INSERT ITEM)?

Take a survey

Participate in an education program

Participate in a group interview

Limit or restrict your diet

Do exercises

Take medicine by mouth

Take a new drug as part of a test

Receive medication by a needle (e.g. shot)

Give blood

Take a DNA test

Give urine

4. Very likely3. Somewhat likely2. Somewhat unlikely1. Very unlikely
Previous participation in researchHave you ever been asked to participate in a medical research study?Yes/no
Have you ever participated in a medical research study?Yes/no
Value of human subjects researchHow do you feel about medical research involving people?5. Very positive4. Somewhat positive3. Neutral2. Somewhat negative1. Very negative
How important to do feel medical research is?3. Very important,2. Somewhat important1. Not important at all
Motivations for participationIf you were asked to be a subject in a medical research study that involved drawing blood, what would make you more likely, less likely, or have no effect on your agreeing to participate?

money

curiosity

close friends or relatives encouraging your participation

close friends or relatives also participating

a close friend or relative has or had the disease being studied

having the disease that is being studied in the research

feeling that the researchers were honest about the risks

free medical care

free transportation

the idea of helping others

helping you (yourself)

3. More likely2. Less likely1. Would have no effectVariable constructed: Assessed with eleven items (a-k) measuring what would make them more likely, less likely, or have no effect in their decision to participate on a medical research study. Response items were recoded as −1 = Less likely, 0 = have no effect, and 1 = more likely. Scale was calculated by the average of 11 items, ranging from −1 to 1.
Patient-provider interactionIf your doctor wanted you to participate in research, you trust he/she would fully explain it to you.Yes/no
Your doctor would not ask you to participate in medical research if he/she thought it would harm you.Yes/no
Beneficiaries of ResearchHow much would (INSERT) benefit from medical research?

Scientists

Your community

Your family or friends

You, yourself

The general public

Variable constructed: Assessed with five items measuring how much participants believed the following groups benefited from medical research (a-e).Scale was calculated by the average of all items, ranging from 1 to 4.
4. A great deal3. A moderate amount2. Only a little1. Not at all
Attitudes about researchHow often, if ever, do you think participants in medical research are pressured into participating?5. Always4. Most of the time3. About Half of the time2. Only occasionally1. Never
Researcher honestyResearchers are always honest with the people they want to participate in their studies.Yes/no
ExperimentationHow likely is it that you, or people with the same race or ethnicity as you, might be used as guinea pigs in research studies without your consent?3. Very likely2. Somewhat likely1. Not likely at all
Race matchingHow important would it be to you to have a researcher or research staff who looks like you ask you to participate in a study3. Very important2. Somewhat important1. Not important at all
Knowledge about the Tuskegee StudyHow much have you heard or read about the Tuskegee Syphilis Study?4. A great deal3. A moderate amount2. Only a little, or1. None at all
Survey questions. Take a survey Participate in an education program Participate in a group interview Limit or restrict your diet Do exercises Take medicine by mouth Take a new drug as part of a test Receive medication by a needle (e.g. shot) Give blood Take a DNA test Give urine money curiosity close friends or relatives encouraging your participation close friends or relatives also participating a close friend or relative has or had the disease being studied having the disease that is being studied in the research feeling that the researchers were honest about the risks free medical care free transportation the idea of helping others helping you (yourself) Scientists Your community Your family or friends You, yourself The general public

Analyses

A two-way chi-square was first performed to examine racial/ethnic differences on categorical variables. All effect sizes were small, i.e., Cramer's V ≤ 0.135. An independent samples t-test was performed on all other variables by race/ethnicity. Cohen's d, an effect size, is reported for each analysis. Three factors were extracted from the items on willingness to participate in a future study by risk level, using maximum likelihood extraction method with direct oblimin rotation. There were five items loading on the first factor (Cronbach's alpha of 0.78), labeled “Risk Level: Do”. These items were: 1) survey, 2) education program, 3) group interview, 4) limited/restricted diet, and 5) exercise. The second factor, labeled “Risk Level: Take”, consisted of three items with a Cronbach's alpha of 0.81: 1) medicine by mouth, 2) new drug, and 3) medication by needle. Lastly, the third factor, labeled “Risk Level: Give”, consisted of three items with a Cronbach's alpha of 0.75: 1) give blood, 2) DNA test, and 3) give urine. There were moderate to large correlations among the three factors. The factor scores were computed by averaging the items on each factor (Table 3).
Table 3

Factor loadings for type of medical research study by risk level.

ItemsRisk Level: DoRisk Level: TakeRisk Level: GiveCommunality
Take a survey0.5650.577
Participate in an education program0.7610.453
Participate in a group interview0.7450.453
Limit or restrict your diet0.4500.641
Do exercises0.4570.713
Take medicine by mouth0.7120.457
Take a new drug as part of a test0.7890.372
Receive medication by needle0.7750.407
Give blood0.4940.613
Take a DNA test0.8440.329
Give urine0.6600.467



Correlation
“Do”1.000
“Take”0.3571.000
“Give”0.6090.4771.000



Cronbach's alpha0.780.810.75
Factor loadings for type of medical research study by risk level. A logistic regression was performed on each outcome variable: 1) willingness to participate in future medical research, and 2) ever participated in a research study. For the “ever participated” outcome, analysis was limited to participants who responded yes to “ever asked” (N = 518). The predictors used for each outcome variable were: socio-demographic variables, value of human subjects research, previous participation, motivations for participation, patient-provider interactions, beneficiaries of research, researcher honesty, experimentation, race matching and the Tuskegee Syphilis Study [29]. Two-way interactions between race and each covariate were tested for the moderating effect of race on covariate-outcome association. Stepwise forward regression was conducted to select significant interactions of race and each covariate included in the model. Several models were tested in order to develop the most parsimonious set of predictors. McFadden pseudo R2 is reported for each model. A multiple regression was performed with the factors extracted from the items on willingness to participate in a future study by risk level as the outcome variables (Do, Take and Give), using the same predictors in Table 5 and same procedures as stated under logistic regression. All analyses were conducted using STATA 14.2.
Table 5

Odds ratio and coefficients for participation in research risk level.

VariableWilling to Participate
Ever Participated
Risk Level: Do
Risk Level: Take
Risk Level: Give
OR (95% CI)OR (95% CI)B (SE)B (SE)B (SE)
Race/Ethnicity
 African American (Ref.)
 Latino6.55 (2.69, 16.0)1.39 (0.69, 2.78)−0.38 (0.9)0.52 (0.11−0.63 (0.14)
Gender
 Males (Ref.)
 Females0.76 (0.59, 0.98)0.86 (0.53, 1.38)0.03 (0.03)−0.21 (0.04)0.02 (0.04)
Age1.02 (0.99, 1.05)1.02 (1.00, 1.03)−0.003 (0.001)0.01 (0.01)0.002 (0.001)
Education
 Below college (Ref.)
 College and above0.72 (0.54, 0.95)0.92 (0.54, 1.56)0.04 (0.03)−0.17 (0.04)−0.40 (0.11)
Marital Status
 Other (Ref.)
 Married or living with partner1.07 (0.83, 1.39)1.14 (0.70, 1.83)0.04 (0.03)0.03 (0.04)0.02 (0.04)
Health Insurance
 No (Ref.)
 Yes1.02 (0.74, 1.40)0.85 (0.46, 1.56)−0.04 (0.03)0.03 (0.05)−0.02 (0.04)
Health Status1.05 (0.93, 1.17)0.95 (0.77, 1.17)0.02 (0.01)0.14 (0.05)0.02 (0.02)
Income (<$ 36,000) (Ref.)
$36,000 - $76,0001.47 (1.08, 2.00)0.97 (0.49, 1.94)0.02 (0.03)−0.04 (0.05)0.10 (0.04)
> $76,0001.71 (1.18, 2.47)1.37 (0.61, 3.08)0.04 (0.04)−0.11 (0.06)0.04 (0.05)



Ever been asked to participate in research
 No (Ref.)
 Yes1.65 (1.21, 2.26)0.07 (0.03)0.12 (0.05)0.05 (0.04)
Value of human subjects research1.45 (1.29, 1.63)0.88 (0.70, 1.12)−0.03 (0.04)0.18 (0.02)−0.02 (0.05)
Motivations for participation in Research46.25 (13.10, 165.34)3.96 (1.87, 8.38)0.38 (0.04)0.39 (0.06)0.57 (0.05)
Patient-Provider: Trust MD fully explain research
 Disagree (Ref.)
 Agree1.92 (1.44, 2.56)2.17 (1.16, 4.04)0.11 (0.03)0.15 (0.05)0.17 (0.04)
Patient-Provider: MD would not ask if research harms you
 Disagree (Ref.)
 Agree0.95 (0.70, 1.27)0.75 (0.42, 1.35)−0.07 (0.03)*−0.01 (0.05)−0.04 (0.04)
Beneficiaries of research2.76 (2.23, 3.41)1.70 (1.11, 2.60)0.19 (0.02)0.16 (0.03)0.17 (0.03)
Researcher are always honest with people
 No (Ref.)
 Yes1.56 (1.20, 2.03)1.02 (0.63, 1.66)0.07 (0.03)0.24 (0.04)0.05 (0.04)
Experimentation: used as guinea pigs1.07 (0.90, 1.28)0.97 (0.71, 1.33)0.04 (0.02)0.01 (0.03)−0.003 (0.02)
How Important: Race Matching1.33 (1.12, 1.58)0.88 (0.65, 1.21)0.03 (0.01)0.13 (0.03)−0.22 (0.07)
Knowledge: Tuskegee Syphilis Study1.13 (1.00, 1.28)0.99 (0.80, 1.22)0.03 (0.01)−0.01 (0.02)−0.02 (0.02)
Race × Age0.98 (0.97, 1.00)
Race × Education0.20 (0.07)
Race × Health status−0.11 (0.03)
Latino × Income ($36,000-$76,000)0.62 (0.21, 1.87)
Latino × Income (>$76,000)0.23 (0.07, 0.75)
Race × Value of human subjects research0.09 (0.02)0.10 (0.03)
Race × Motivations for participation in research0.40 (0.18, 0.86)
Race × How Important: Race Matching0.12 (0.05)
R2 (full model)0.290.100.230.260.20

Boldface indicates statistical significance.

Results

Descriptive statistics for demographic, research participation, patient-provider, and other selected variables are reported by race/ethnicity in Table 4. Most effect sizes were small: Cramer's V ≤ 0.10 and Cohen's d ≤ 0.20. More African Americans than Latinos had been asked to participate in research (27% vs 15% respectively), although Latinos were more willing to participate in future research. African Americans were more skeptical of medical research studies than Latinos, based on their responses to the experimentation items. In addition, both groups felt medical research was somewhat to very important (Mean (SD) = 2.87(.37) for African Americans and 2.87(.35) for Latinos).
Table 4

Descriptive statistics by race and ethnicity.

VariableCategoryAfrican Americans
Latinos
Cramer's V
N (%)N (%)
Genderfemale801 (68%)782 (63%)0.056
Educationcollege or above656 (56%)564 (45%)0.108
Marital Statusmarried579 (50%)792 (63%)0.135
Health Insuranceyes966 (82%)922 (74%)0.106
Income< $36,000573 (56%)612 (56%)0.011
$36,000 - $76,000276 (27%)292 (27%)
> $76,000172 (17%)194 (18%)
Willingness to participateYes668 (57%)856 (68%)0.114
Prior Participation: Ever been asked to participate in a medical research studyYes324 (27%)194 (15%)0.146
Prior Participation: Ever participated in researchYes204 (63%)125 (65%)0.014
Researcher honestyYes380 (34%)524 (44%)0.102
Experimentation: Doctors given treatment w/o permissionYes228 (20%)206 (17%)0.040
Patient-Provider: Trust fully explain it to youagree927 (79%)917 (73%)0.069
Patient-Provider: Not ask to participate if harm youagree903 (78%)950 (76%)0.018
Attitude: Pressured to participatenever219 (19%)260 (22%)0.066
only occasionally406 (36%)461 (38%)
about half of the time285 (25%)279 (23%)
most of the time180 (16%)150 (12%)
Always41 (4%)58 (5%)
Descriptive statistics by race and ethnicity.

Pressured to participate

Just over a third of African Americans and Latinos thought that participants were occasionally pressured into participating. An additional 25% of African Americans and 23% of Latinos believed that participants were pressured half of the time. Furthermore, 20% of African Americans and 17% of Latinos felt participants are pressured most of the time or always (Table 4).

Race matching

In response to the question about importance of race-matched researchers, over half of both groups replied “not at all important” (57% and 51%, African Americans and Latinos, respectively) and 30% of Latinos and 28% of African Americans said it was somewhat important. Less than 20% of each group indicated it was very important.

Motivations for participation

The top reasons for deciding to participate in a study were: 1) helping others; 2) helping yourself); 3) having the disease being studied; 4) having a relative or close friend with the disease being studied; and 5) researchers' honesty about risks. Responses were comparable across the two groups (Data not shown).

Research participation

Participants reported a high level of willingness to participate in numerous types of research studies especially those in the “Do” factor. There were no statistically significant differences between groups on these items. For the “Take” factor, 50% of African Americans and 53% of Latinos stated they would be willing to take medicine as part of a research study. In addition, 30% of African Americans and 36% of Latinos said they would take a new drug. These differences between African Americans and Latinos for the “Take” factor were statistically significant. For the “Give” factor, there were statistically significant differences for giving blood and giving DNA, but not for giving urine. Over 70% of both groups reported they would take a DNA test (Data not shown). Table 5 shows the odds ratio and regression coefficients for predicting willingness to participate, ever participated, and risk level of research study. Overall, 29% of variability in the willingness to participate in a future medical research study was explained. Compared to Latinos, African Americans tend to have higher odds of participating in a medical research study as age (OR = 0.98) or motivation (OR = 0.4) increases. Female participants with low-income level or high education level were less likely to participate than low-income participants. Factors that increased likelihood of participation were: 1) value of human subjects research; 2) previously asked to participate; 3) Trust MD fully explain research; 4) Researchers are honest; 5) belief that people benefit from research; 6) Race Matching; and 7) Knowledge: Tuskegee Syphilis Study. In order to develop the most parsimonious model, other predictors listed in Table 4 were left out of the models (Table 5) if R [2] increased by less than .01. Odds ratio and coefficients for participation in research risk level. Boldface indicates statistical significance. The second column in Table 5 provides the odd ratios for “ever participated.” About 21% of participants (n = 518) reported having been asked to participate in a medical research study (27% of African Americans vs. 15% of Latinos). Of those asked to participate, 63% of African Americans and 65% of Latinos participated. Older respondents were more likely to have participated than younger respondents, as were those with higher motivation for participation, who believed others benefitted from research, and had greater trust in doctors. Compared to Latinos, African Americans in high-income levels tend to have higher odds of ever participated. In Table 5, columns 3–5 show the beta coefficients for the risk level factors. The demographic variables were highly significant for what the participants were willing to “Take”: 1) females were less likely than males, 2) older respondents were more willing than younger respondents, and 3) college educated individuals were less willing than those with no college education. Compared to African Americans, Latinos were less willing to “take” as health status improves. For willingness to “Do”, older participants were less willing than younger participants. Latinos were more willing to “Do” than African Americans as they agree with the value of human subjects' research. For willingness to “Give,” only income was significant. Compared to African Americans, Latinos are more willing to give as their education levels, valuing of human subjects' research, or importance of race matching increases. There were similar predictors that were significant for the willingness to participate in a future research study and the factors of the different levels of risk, including 1) being more influenced by motivational factors, 2) Trust MD fully explain research, and 3) believing people benefitted from research. For willingness of “Do” and “Take”, predictors of 1) ever been asked to participate in research, and 5) feeling researchers were honest (only for “Take”) have significant positive impact. Few predictors were significant for one type of risk level factor of a research study but not others.

Discussion

This is one of the few studies to investigate differences between African Americans and Latinos on factors associated with participation in research. Key results include several issues that have not yet been covered in the literature using empirical data: 1) the importance of race matching, 2) differential willingness according to three novel levels of study risk, and 3) a normative belief that individuals are frequently pressured into research. One reason identified in this study for continued underrepresentation of minorities in research is that participants are not being asked to participate. In our study, only 27% of African Americans and 15% of Latinos were ever asked to participate in medical research. Of those who were asked, over 60% did participate, indicating a willingness to participate that supports the findings of several previous studies [6], [9], [30], [31]. Thus, one way to overcome the underrepresentation of minorities may be, simply, to ask. Particularly with regard to clinical trials, many minorities would not only be willing to participate if asked by their doctor, but also expect that the information about research should come from their physicians [32], [33]. Researchers outside the clinical environment might consider partnering with community physicians as a way to improve their recruitment efforts. Some studies suggest that researchers' preconceived ideas about minorities' unwillingness to participate leads them to not ask, believing the response will be no [23]. With recent evidence suggesting that minorities are indeed willing to participate, researchers may need to examine their own biases, and if present, overcome them [5], [13], [34]. Therefore, research training may be helpful. Quinn and colleagues found that training on recruitment of racial and ethnic minorities was associated with the use of a greater number and more diverse recruitment strategies, and other studies support that varied recruitment strategies are effective for recruiting minorities into research [34]. Previous studies reported several motivations for minorities to participate in research, including altruism, money and others [15], [20], [35]. In our research, four of the top five motivators for participation (e.g., helping others, helping yourself, have the same disease being studied, relative/close friend have the disease being studied) are supported by the literature. In our study, however, money ranked only seventh, behind the belief that researchers were honest about the risk. The finding that researcher honesty is an important motivator for participation reinforces the need for careful attention to making the informed consent process a true conversation in which trust is established between the participant and the researcher [36]. Race matching of research staff to potential participants is used by many researchers for recruitment [20], [26], [34]. For example, Quinn et al. [34] found that almost 80% of “comprehensive researchers” reported matching the race and ethnicity of the recruiter to the target population. Yet we found that more than 50% of participants reported that it was not important. While the temptation to simply ‘match’ by race is strong, it neglects the more complicated issues of class, education, individual personality, and institutional reputation that can also affect recruitment. Although race matching could be critical in some cultures and contexts, in our study, researcher honesty and shared values were more important than racial concordance. Previous literature has differed on the association between level of risk and willingness to participate. We found that African Americans and Latinos are not automatically predisposed to decline participation in research, including potentially controversial research involving DNA. This is consistent with a recent study in which African Americans were likely to report interest in participation across an array of studies including giving blood and providing biological material for a DNA sample, although in that study, African Americans and Latinos were least willing to take a medication as part of a study, which differs considerably from our results [37]. We empirically identified three novel factors illustrating the level of risk, named “Do”, “Take” and “Give”, which did not differ by race/ethnicity. Our results provide evidence of minority willingness to participate across risk levels, which is useful for researchers who may have been reticent to recruit minorities for higher risk studies such as clinical drug trials or potentially sensitive genomic research. The question of risk of a specific study is an important consideration for participants, and yet it is not an insurmountable obstacle to recruitment. An interesting and novel finding that emerged from our study was the issue of being pressured into participating in research. Despite the current human subjects protections in place today and individuals' willingness to participate, we still found that 60% reported they believed people in medical research are pressured into participating and over 17% felt individuals are pressured most or all the time. Respondents who believed people are pressured into participating in research did not differ on the variables of: ever being asked, ever participated, race/ethnicity or level of risk. There was, however, a moderate correlation between level of risk and pressure. This reinforces the need to create an open and honest dialogue between researchers and potential participants, both by providing community education about research, and by enhancing the capacity of researchers to effectively engage participants in a dialogue during the informed consent process [36].

Limitations

To our knowledge, this study is the first to utilize an all-minority sample to examine willingness to participate in research and the largest sample size of minority respondents in any survey assessing attitudes and willingness to participate in research; however, this study did not include a White referent group, which may be considered a limitation by some investigators. In addition, our sample is not representative of all African American and Latino populations but of those who live in predominantly African American and Latino neighbourhoods.

Conclusion and future research

Our results provide evidence that despite their underrepresentation in research trials, minorities are willing to participate in a wide array of research studies and risk levels. Concurrently, respondents indicated concern about researcher honesty and pressure, suggesting a need for more educational or outreach efforts to minority populations, which would include a general discussion of the value of research, acknowledge past abuses, increase understanding of human subjects protections today, and empower individuals to make an informed decision about participation. Further training for researchers, focused on specific recruitment of racial and ethnic minorities, could assist investigators in developing greater skills and confidence in their abilities to successfully recruit racial and ethnic minorities in their studies.

Conflict of interest statement

The authors have no conflicts of interest to report. Also, the study sponsor (National Institutes of Health) did not have any role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication.

Financial disclosure

The authors have no financial disclosures to report.

Disclaimer

This article was prepared while N.A. Brown was employed at University of Maryland College Park. The opinions expressed in this article are the authors' own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government.
  34 in total

1.  Utilization of health care services and willingness to participate in future medical research: the role of race and social support.

Authors:  Besangie Sellars; Mary A Garza; Craig S Fryer; Stephen B Thomas
Journal:  J Natl Med Assoc       Date:  2010-09       Impact factor: 1.798

Review 2.  Why ethnic minority groups are under-represented in clinical trials: a review of the literature.

Authors:  Mahvash Hussain-Gambles; Karl Atkin; Brenda Leese
Journal:  Health Soc Care Community       Date:  2004-09

3.  Challenging assumptions about minority participation in US clinical research.

Authors:  Jill A Fisher; Corey A Kalbaugh
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

4.  Attributes of researchers and their strategies to recruit minority populations: results of a national survey.

Authors:  Sandra Crouse Quinn; James Butler; Craig S Fryer; Mary A Garza; Kevin H Kim; Christopher Ryan; Stephen B Thomas
Journal:  Contemp Clin Trials       Date:  2012-07-05       Impact factor: 2.226

Review 5.  Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

Authors:  Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

6.  African Americans' views on research and the Tuskegee Syphilis Study.

Authors:  V S Freimuth; S C Quinn; S B Thomas; G Cole; E Zook; T Duncan
Journal:  Soc Sci Med       Date:  2001-03       Impact factor: 4.634

7.  Who refuses enrollment in cardiac clinical trials?

Authors:  Mimi Sen Biswas; L Kristin Newby; Lori A Bastian; Eric D Peterson; Jeremy Sugarman
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

8.  Willingness to participate in cardiac trials.

Authors:  Eric D Peterson; Barbara L Lytle; Mimi S Biswas; Laura Coombs
Journal:  Am J Geriatr Cardiol       Date:  2004 Jan-Feb

9.  Community needs, concerns, and perceptions about health research: findings from the clinical and translational science award sentinel network.

Authors:  Linda B Cottler; Donna Jo McCloskey; Sergio Aguilar-Gaxiola; Nancy M Bennett; Hal Strelnick; Molly Dwyer-White; Deborah E Collyar; Shaun Ajinkya; Sarena D Seifer; Catina Callahan O'Leary; Catherine W Striley; Bradley Evanoff
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

10.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

View more
  24 in total

Review 1.  International Society of Psychiatric Genetics Ethics Committee: Issues facing us.

Authors:  Gabriel Lázaro-Muñoz; Maya Sabatello; Laura Huckins; Holly Peay; Franziska Degenhardt; Bettina Meiser; Todd Lencz; Takahiro Soda; Anna Docherty; David Crepaz-Keay; Jehannine Austin; Roseann E Peterson; Lea K Davis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-05-23       Impact factor: 3.568

2.  Comparison of Recruitment Strategies for Engaging Older Minority Adults: Results From Take Heart.

Authors:  Jessica E Ramsay; Cainnear K Hogan; Mary R Janevic; Rebecca R Courser; Kristi L Allgood; Cathleen M Connell
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-04-17       Impact factor: 6.053

3.  Linking Education to Action: A Program to Increase Research Participation Among African American Women.

Authors:  Carmen Radecki Breitkopf; Karen Patricia Williams; Jennifer L Ridgeway; Monica W Parker; Alice Strong-Simmons; Sharonne N Hayes; Michele Y Halyard
Journal:  J Womens Health (Larchmt)       Date:  2018-07-05       Impact factor: 2.681

Review 4.  Integrating DNA Methylation Measures of Biological Aging into Social Determinants of Health Research.

Authors:  Laurel Raffington; Daniel W Belsky
Journal:  Curr Environ Health Rep       Date:  2022-02-18

5.  Reweighting to address nonparticipation and missing data bias in a longitudinal electronic health record study.

Authors:  Milena A Gianfrancesco; Charles E McCulloch; Laura Trupin; Jonathan Graf; Gabriela Schmajuk; Jinoos Yazdany
Journal:  Ann Epidemiol       Date:  2020-07-02       Impact factor: 3.797

6.  Motivational interviewing to reduce risky sexual behaviors among at-risk male youth: A randomized controlled pilot study.

Authors:  Shayna S Bassett; Daniel J Delaney; Amy M Moore; Mary Clair-Michaud; Jennifer G Clarke; L A R Stein
Journal:  Psychol Serv       Date:  2021-01-07

7.  Developing and Launching a Research Participant Registry.

Authors:  Jean C McSweeney; Beatrice Boateng; Laura James; Pearl Anna McElfish; David Robinson; Sandra E Hatley; Pamela Christie; Nia Indelicato
Journal:  Health Commun       Date:  2018-05-01

8.  Factors associated with willingness to participate in a vaccine clinical trial among elderly Hispanic patients.

Authors:  Sharon Rikin; Steven Shea; Philip LaRussa; Melissa Stockwell
Journal:  Contemp Clin Trials Commun       Date:  2017-06-24

9.  Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis.

Authors:  Parita Patel; Charles Muller; Sonali Paul
Journal:  World J Hepatol       Date:  2020-08-27

10.  Willingness to Participate in Health Research Among Community-Dwelling Middle-Aged and Older Adults: Does Race/Ethnicity Matter?

Authors:  Sadaf Arefi Milani; Michael Swain; Ayodeji Otufowora; Linda B Cottler; Catherine W Striley
Journal:  J Racial Ethn Health Disparities       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.